IBB vs IHE: holdings overlap, shared companies and scores
As of September 11, 2026, IBB and IHE overlap 2.9% by weight. iShares Biotechnology ETF (IBB): U.S. biotechnology stocks. iShares U.S. Pharmaceuticals ETF (IHE): U.S. pharmaceutical manufacturers.
Updated September 11, 2026
How much do IBB and IHE overlap?
As of September 11, 2026, IBB and IHE overlap 2.9% by weight.
3% of IBB is already inside IHE.
9% of IHE is already inside IBB.
IBB holds 239 companies and IHE holds 56; 20 are in both.
Computed by ETF Copilot from both funds' holdings rather than quoted from a data provider, and rebuilt nightly.
How does ETF Copilot score IBB and IHE?
As of September 11, 2026, ETF Copilot scores IBB 3.1 out of 10 and IHE 6.4 out of 10.
They differ most on Growth: IBB 1.9 and IHE 8.5.
The five factor scores behind them are set out below, 0–10 and higher is better, ranked against every US equity ETF we track.
| Factor | IBB | IHE |
|---|---|---|
| Growth | 1.9 | 8.5 |
| Valuation | 3.5 | 4.1 |
| Risk | 4.2 | 6.6 |
| Quality | 3.4 | 7.1 |
| Return | 3.1 | 5.1 |
IHE is the cheaper of the two at 0.37% a year
As of September 11, 2026, IBB charges 0.44% a year, yields 0.46% and holds $10.7B in assets across 239 positions.
As of September 11, 2026, IHE charges 0.37% a year, yields 1.83% and holds $1.7B in assets across 56 positions.
| Measure | IBB | IHE |
|---|---|---|
| Expense ratio | 0.44% | 0.37% |
| Dividend yield | 0.46% | 1.83% |
| Assets under management | $10.7B | $1.7B |
| Holdings | 239 | 56 |
Expense ratio, dividend yield and assets under management are reported by the fund and refreshed daily. Every other figure on this page is computed by ETF Copilot.
Where IBB and IHE trade against their own history
IBB trades at 22.7 times earnings, against its own median of 21.5, and is more expensive than 60% of its own 114 monthly readings since 2017.
IHE trades at 27.3 times earnings, against its own median of 22.5, and is more expensive than 89% of its own 114 monthly readings since 2017.
What moved IBB and IHE this week
IBB fell 5.1% in the week to September 11, 2026. The holdings that moved it most were Amgen (−15.0%), Vertex Pharmaceuticals (−7.6%) and Regeneron Pharmaceuticals (−7.3%); Roivant Sciences (+18.6%) pushed the other way.
IHE fell 4.1% in the week to September 11, 2026. The holdings that moved it most were Johnson & Johnson (−4.6%), Eli Lilly (−3.8%) and Royalty Pharma (−8.2%); Axsome Therapeutics (+6.0%) pushed the other way.
What do IBB and IHE each hold?
What's inside IBB: AI 1%.
48% of IBB is its ten largest holdings.
78% of IHE is its ten largest holdings.
Compare with similar funds
Cite this
ETF Copilot, “IBB vs IHE holdings overlap and scores”, as of September 11, 2026.
https://etf-copilot.com/compare/ibb-vs-ihe
Register free to unlock IBB vs IHE prices and holdings on ETF Copilot.
Register free →